When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
KYKOF - Aveo up 35% premarket on Kyowa Kirin buy back of tivozanib rights
Kyowa Hakko Kogyo
AVEO Oncology (NASDAQ:AVEO) and Kyowa Kirin Co., Ltd. (OTCPK:KYKOF) have amended their license agreement allowing the latter to repurchase the non-oncology rights to tivozanib in AVEO territories, including the U.S. and EU. Under their original 2006 contract, AVEO had exclusive rights for all indications.
More news on: AVEO Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd., Healthcare stocks news, Stocks on the move,